Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100054038Phase 4Recruiting
Phase 4 trial of esketamine in postoperative pain (4 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Resting NRS pain assessment score. Started Dec 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100054038.